Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism HIF-2α inhibitors(Endothelial PAS domain-containing protein 1 inhibitors), VEGF inhibitors(Vascular endothelial growth factor inhibitors), VHL inhibitors(von Hippel-Lindau tumor suppressor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Digestive System Disorders | Discovery | - | 03 Oct 2023 | |
| Immune System Diseases | Discovery | - | 03 Oct 2023 | |
| Neoplasms | Discovery | - | 03 Oct 2023 | |
| Nephritis | Discovery | - | 03 Oct 2023 | |
| Other Diseases | Discovery | - | 03 Oct 2023 | |
| Pneumonia | Discovery | - | 03 Oct 2023 | |
| Skin and Musculoskeletal Diseases | Discovery | - | 03 Oct 2023 | |
| Surgical Wound Infection | Discovery | - | 03 Oct 2023 |





